A A AText only | Accessibility | Privacy and cookies

Browse site A to Z

Search results

Go To Advanced Search

You could also try: resembling (46)

Nivolumab-Relatlimab

Description
Chemotherapy Protocol SKIN CANCER Nivolumab in combination with Relatlimab (Opdualag) Regimen • Skin – Nivolumab in in combination with Relatlimab (Opdualag) Indication The
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Skincancer/Nivolumab-Relatlimab-Ver1.pdf

Cisplatin-Lomustine-Vincristine (Packer LCV3)

Description
Chemotherapy Protocol Central Nervous System CISPLATIN-LOMUSTINE-VINCRISTINE (Packer LCV3) Regimen • CNS – Cisplatin-Lomustine-Vincristine (Packer LCV3) Indication • Adjuvant treatment for
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/CNS/Cisplatin-Lomustine-Vincristine-Packer-LCV3.pdf

NIHR BRC Academic Career development Lead_2024-04-30_final

Description
NIHR BRC Academic Career Development Lead Call for expressions of interest The University Hospital Southampton NHS Foundation Trust (UHS) and University
Url
/Media/Southampton-Clinical-Research/Downloads/NIHR-BRC-Academic-Career-development-Lead-2024-04-30-final.pdf

Professor Graham Burdge

Description
Professor Graham Burdge Graham Burdge passed away at home on the 1st February 2024 as the result of a brain tumour
Url
/Media/Southampton-Clinical-Research/Downloads/Professor-Graham-Burdge.pdf

Abemaciclib-Letrozole

Description
Chemotherapy Protocol Breast Cancer Abemaciclib-Letrozole Regimen • Breast Cancer – Abemaciclib-Letrozole Indication • Abemaciclib in combination with an aromatase inhibitor is indicated
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Breastcancer/Abemaciclib-Letrozole.pdf

Alemtuzumab

Description
Chemotherapy Protocol TPLL Regimen Alemtuzumab • TPLL – Alemtuzumab Indication • The treatment of adult patients with TPLL in the first line setting. In
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/TPLL/Alemtuzumab-Ver1.pdf

Cyclophosphamide-Epirubicin-Paclitaxel 21day

Description
Chemotherapy Protocol BREAST CANCER CYCLOPHOSPHAMIDE-EPIRUBICIN-PACLITAXEL Regimen • Breast Cancer – Cyclophosphamide-Epirubicin-Paclitaxel Indication • Neoadjuvant / adjuvant therapy of early breast cancer
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Breastcancer/Cyclophosphamide-Epirubicin-Paclitaxel-21day.pdf

Differences in sex development (DSD) clinic - patient information

Description
This factsheet explains what the differences in sex development (DSD) clinic is, why your child has been referred to the clinic
Url
/Media/UHS-website-2019/Patientinformation/Childhealth/Differences-in-sex-development-DSD-clinic-3504-PIL.pdf

Bevacizumab(15mgkg) Carboplatin Gemcitabine (day1)

Description
Chemotherapy Protocol GYNAECOLOGICAL CANCER BEVACIZUMAB (15)-CARBOPLATIN (AUC4)-GEMCITABINE (day 1) This protocol may require funding Regimen • Ovary-Bevacizumab (15)-Carboplatin
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Ovarian-cancer/Bevacizumab15mgkg-Carboplatin-Gemcitabine-day1.pdf

Carboplatin-Vinorelbine Oral

Description
Chemotherapy Protocol LUNG CANCER – NON-SMALL CELL (NSCLC) CARBOPLATIN (AUC6)-VINORELBINE (Oral) Regimen  NSCLC – Carboplatin (AUC6)-Vinorelbine (Oral) Indication  First line
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lung-cancer-non-small-cellNSCLC/Carboplatin-Vinorelbine-Oral.pdf
371 to 380 of 757
Previous … 36 37 38 39 40 … Next